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Abstract
Background: Drugs & used in anticancer chemotherapy have severe effects upon the cellular
transcription and replication machinery. From in vitro studies it has become clear that these drugs
can affect specific genes, as well as have an effect upon the total transcriptome.
Methods: Total mRNA from two skin lesions from a single AIDS-KS patient was analyzed with the
SAGE (Serial Analysis of Gene Expression) technique to assess changes in the transcriptome
induced by chemotherapy. SAGE libraries were constructed from material obtained 24 (KS-24) and
48 (KS-48) hrs after combination therapy with bleomycin, doxorubicin and vincristine. KS-24 and
KS-48 were compared to SAGE libraries of untreated AIDS-KS, and to libraries generated from
normal skin and from isolated CD4+ T-cells, using the programs USAGE and HTM. SAGE libraries
were also compared with the SAGEmap database.
Results: In order to assess the primary response of AIDS-related Kaposi's sarcoma (AIDS-KS) to
chemotherapy in vivo, we analyzed the transcriptome of AIDS-KS skin lesions from a HIV-1
seropositive patient at two time points after therapy. The mRNA profile was found to have changed
dramatically within 24 hours after drug treatment. There was an almost complete absence of
transcripts highly expressed in AIDS-KS, probably due to a transcription block. Analysis of KS-24
suggested that mRNA pool used in its construction originated from poly(A) binding protein (PABP)
mRNP complexes, which are probably located in nuclear structures known as interchromatin
granule clusters (IGCs). IGCs are known to fuse after transcription inhibition, probably affecting
poly(A)+RNA distribution.
Forty-eight hours after chemotherapy, mRNA isolated from the lesion was largely derived from
infiltrating lymphocytes, confirming the transcriptional block in the AIDS-KS tissue.
Conclusions: These in vivo findings indicate that the effect of anti-cancer drugs is likely to be more
global than up- or downregulation of specific genes, at least in this single patient with AIDS-KS. The
SAGE results obtained 24 hrs after chemotherapy can be most plausibly explained by the isolation
of a fraction of more stable poly(A)+RNA.
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Background
Existing anti-cancer drugs are generally seen as non-specif-
ic anti-mitotic agents, inducing apoptosis in all rapidly di-
viding cells by interfering with DNA replication and the
cell cycle. Distinct combinations of chemotherapeutic
agents have been found empirically to be beneficial treat-
ing different types of cancer. E.g. bleomycin is used to
treat squamous cell carcinoma, lymphomas, and testicu-
lar tumors, while doxorubicin (Adriamycin™) is used to
combat acute lymphoblastic and myeloblastic leukemia,
Wilms' tumor, soft tissue and osteogenic sarcomas, neu-
roblastoma, cancer of the breast, ovaries, lungs, bladder,
and thyroid, lymphomas, bronchogenic and gastric carci-
noma, and Kaposi's sarcoma. Vinca alkaloids (vinblastine,
vincristine and vindesine) are used in the treatment a wide
variety of tumors including lymphomas, breast cancer,
Kaposi's sarcoma, testicular cancer, leukemia and neurob-
lastoma. To treat AIDS-KS, a cocktail of doxorubicin, ble-
omycin and vincristine is at present a widely used
chemotherapy.
Anti-cancer drugs have been shown to inhibit cell cycle
progression by interfering with microtubule formation
and DNA replication, and to induce apoptosis probably
through DNA damage. In vitro studies have elucidated
some aspects of how this is achieved. Micro-array analysis
has indicated that anticancer drugs could be clustered ac-
cording to the specific gene expression pattern they in-
duced in cultured cells, with drugs with a same known
mode of action generating a similar change in mRNA lev-
els [1]. Vinca alkaloids are known to interfere with micro-
tubule formation at the protein level, resulting in G2/M
phase arrest, inhibition of cell proliferation and apoptosis
[2]. Doxorubicin also induces cell-cycle arrest at the G2/M
checkpoint [3] and induces apoptosis, probably by direct-
ly intercalating into double-stranded DNA [4], or by form-
ing drug-DNA adducts, which also prevents DNA
replication [5]. Doxorubicin can effectively chelate Fe3+,
and subsequently cleave DNA through the production of
hydroxyl radicals [6–9]. It was also shown that doxoru-
bicin can inhibit RNA polymerase II [10], and the helicase
activity of the RNA helicase II/Gu-protein complex, prob-
ably by binding to its RNA substrates [11]. However, all
these effects were seen in vitro at relatively high concentra-
tions of the drug. At plasma concentrations, the main ac-
tion of doxorubicin is probably inhibition of
topoisomerase II [12], although helicase inhibition could
also be achieved with clinically relevant concentrations.
Gene expression profiling clustered doxorubicin with the
topoisomerase II inhibitors [1]. Bleomycin has been
shown to induce G2 block [13], inhibit DNA [14] and
RNA synthesis [15], and induce apoptosis [16]. In addi-
tion, bleomycin mediates the degradation of DNA
[17,18], especially of active chromatin [19], and of all
classes of cellular mRNAs [20]. In vitro, bleomycin upreg-
ulates alpha 1 (I) collagen, fibronectin and decorin mR-
NAs [21] and connective tissue growth factor mRNA [22],
in line with its capability to induce pulmonary fibrosis as
a side-effect.
Analysis of the complete transcriptome (all mRNAs
present in a cell) has been shown to be a powerful way of
detecting genes specifically expressed, or up/down-regu-
lated under certain conditions. The most widely used
methods used for large-scale gene expression analysis to-
day are micro-arrays and SAGE [23]. One important dif-
ference between these methods is that on micro-arrays
internal fragments of a transcript are essential for positive
identification, while with SAGE only 3' ends of transcripts
are captured, and a transcript is identified by a 14 nucle-
otide stretch at its 3' end. Both methods have been used
already on a large variety of tissues, cells, and cell cultures.
Cancer tissue from patients was used in several SAGE stud-
ies (see e.g. [24–26]), but the short-term effect of chemo-
therapy on overall gene expression has not been studied
to date.
To examine the effect of chemotherapy on gene expres-
sion profiles in vivo, we performed SAGE on two AIDS-KS
tissue samples taken from a single patient, 24 and 48 hrs
after treatment with a cocktail of doxorubicin, bleomycin,
and vincristine. These two SAGE libraries were compared
with SAGE libraries derived from tumor tissue from two
untreated AIDS-KS patients, a SAGE library generated
from normal skin, and with a SAGE library from isolated
CD45+CD4+ T-cells.
Kaposi's sarcoma (KS), a relatively rare disease, is now en-
countered more often in HIV-infected homosexual men.
Characteristic for KS are proliferating spindle-shaped
cells, inflammatory cell infiltration, and profound angio-
genesis. Two viruses play a role in AIDS-KS: human im-
munodeficiency virus (HIV), and human herpesvirus 8
(HHV8, also known as Kaposi's Sarcoma-associated Her-
pes Virus, KSHV). Immune suppression by HIV could be a
mechanism facilitating HHV8 replication, with the HHV8
genome containing many genes able to deregulate the cell
cycle such as chemokines, growth factors, a G-coupled re-
ceptor, cyclins and anti-apoptotic genes (for a review see:
[27]). HHV8 can infect a variety of cells, including B cells,
vascular endothelial cells, keratinocytes, monocytes, and
macrophages [28–31]. It also is involved in two other
types of cancer: primary effusion lymphoma (a B-cell lym-
phoma) [32], and multicentric Castleman's disease [33].
Results
SAGE library characteristics
Two SAGE libraries were constructed from treated AIDS-
KS tissue. A total of 47,298 tags were sequenced from the
SAGE library obtained 24 hrs after the start of the firstBMC Cancer 2002, 2 http://www.biomedcentral.com/1471-2407/2/21
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course of chemotherapy (library KS-24), while 46,671
tags were sequenced from the SAGE library derived from a
tumor biopsy taken 48 hrs after treatment (KS-48). Li-
brary characteristics are summarized in Table 1. Charac-
teristics for the control libraries from untreated AIDS-KS
(KSa and KSb), normal skin (NS), and CD4+ T cells
(CD4) are also presented in Table 1. Tag frequencies are
very similar for all six SAGE libraries, but the libraries KS-
24 and KS-48 generated from the drug-treated material
show a higher number of tags that appear only once. Also,
the amount of unique tags is higher in KS-24, KS-48 and
CD4 compared to KSa, KSb and NS. More tags are differ-
entially expressed tags between library KS-24 and the oth-
er three AIDS-KS libraries (Table 2). Statistical correlation
analysis was performed using all six SAGE libraries in pair-
wise comparisons. Pearson correlation coefficients were
calculated for each comparison (Table 3). The two un-
treated KS libraries have a correlation coefficient of 0.83,
indicating a high level of similarity. Surprisingly, the
SAGE library obtained 48 hrs after chemotherapy, KS-48,
shows a high correlation coefficient of 0.92 with SAGE li-
brary CD4, suggesting that mRNA isolated from this biop-
sy is mainly derived from infiltrating T-cells. Histological
analysis of the paraffin embedded tissue of KS-24 and KS-
48 with anti-CD3 antibodies showed at least a two-fold
increase of the amount of T-cells in KS-48 compared with
KS-24 (result not shown). Library KS-24 has the lowest
correlation coefficients observed with both untreated
AIDS-KS libraries (0.38 and 0.37, respectively), suggesting
that the RNA pool isolated after chemotherapy is signifi-
cantly different from that in untreated AIDS-KS. Hierar-
chical clustering performed with the program Cluster
using the Average Linkage Clustering option, and all tag
counts that appear at least twice in at least one of the
SAGE libraries, confirmed that the expression pattern of
KS-24 is greatly different from that of the other libraries
(Fig. 2). KS-48 clusters with library CD4 in this tree, in line
with the high correlation coefficient of the two libraries.
Apoptotic cells could be seen in the H&E stained paraffin
sections of both time points (24 hr and 48 hr), whereby
apoptosis was most pronounced in the epidermis of the
24 hrs biopsy (Fig. 1).
Figure 1
Hematoxylin-eosin (H&E) staining of the AIDS-KS
lesions used for SAGE Two skin biopsies were taken from
a single patient, respectively 24 hrs (top panel) and 48 hrs
(lower panel) after start of chemotherapy with doxorubicin,
bleomycin and vincristine. In both biopsies, endothelial cell
proliferations are seen in the dermis consistent with plaque
stage Kaposi's sarcoma. The elongated nuclei of these cells
show moderate atypia. Within the spindle cell areas, narrow
slits containing erythrocytes are visible. Immunohistochemis-
try demonstrated that in both lesions the atypical spindle
cells are CD31 and HHV8 positive (not shown). Additionally,
in the upper panel, many apoptotic keratinocytes with
nuclear dust are found scattered over the basal layer of the
epidermis. This histologically visible therapy effect was not
conspicuous any more after 48 hours. Both lesions contain
sparse inflammatory cell infiltrates.
Figure 2
Clustered display of SAGE gene expression data Clus-
ter tree is based upon an average linkage analysis of the six
SAGE libraries [56]. Only tags that appear at least twice in at
least one of the libraries have been used.
KS-24 CD4 KS-48 KSa KSb NSBMC Cancer 2002, 2 http://www.biomedcentral.com/1471-2407/2/21
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Highest tag counts in KS-24
The twenty-five highest tags counts found in library KS-24
have been summarized in Table 4. Six out of twenty-five
highest tags in KS-24 do not identify single genes, but
match over 20 transcripts. One tag matches three genes.
Of the highest tags that do identify single genes, two tags
identify mitochondrial transcripts, and 9 represent ribos-
omal protein (RP) mRNA's. RP S29 has the highest tag
count of these RP tags. Doxorubicin has been reported to
induce RP S29 mRNA [34].
Effect of chemotherapy after 24 hrs: disappearance of KS 
tags
In another study a SAGE gene expression profile of AIDS-
KS is reported (Cornelissen et al., manuscript submitted).
Here, 64 genes significantly overexpressed in AIDS-KS li-
braries KSa and KSb were tabulated. Comparing this
AIDS-KS signature expression with library KS-24, only 6/
64 tags were found to be expressed at approximately the
same level, while for 56/64 tags their expression was re-
duced to very low or zero in KS-24. For the first twenty-
one tags, the results are shown in Table 5. Two tags, one
with no reliable matches, and the other corresponding to
prothymosin-, were expressed somewhat higher, but not
more than twofold, after chemotherapy. Expression of the
prothymosin- gene is cell cycle regulated, and the pro-
tein is involved in proliferation checkpoints.
In general, classes of genes whose expression was absent
or significantly decreased in KS-24 included cytokines,
chemokines, collagens, keratins, S100 calcium-binding
proteins, MHC components, and integrins (not shown).
Elevated tag counts (> 3-fold increase) include those for
seven ribosomal proteins (S25, large P1, L7, S29, L37,
S27a, L23), glutaminyl tRNA-synthetase, transcription
factors, translation initiation/elongation factors (includ-
ing cyclin T), poly(A) binding proteins, cyclins (B1, B2,
D3), and four tags representing parts of the T-cell receptor
( chain, CD3D antigen delta polypeptide, CD3G antigen
gamma peptide, CD3Z antigen zeta polypeptide). No tags
were detected for the -chain of the T-cell receptor. In the
CD4 library, tags for the -chain were found, but not for
the  chain, or any other component of the CD3 antigen.
Effect of chemotherapy: decrease of nuclear rRNA but not 
mitochondrial rRNA tags
For doxorubicin it is known that, probably through topoi-
somerase II inhibition, the drug has a dramatic negative
effect upon 18S rRNA transcription in vitro[35]. Normally,
rRNA tags are ignored as artifacts in SAGE libraries as ide-
ally the SAGE procedure should start with only poly(A)
mRNA. However, despite the mRNA purification step and
the fact that rRNAs do not possess poly(A) tails, all SAGE
libraries created to date contain fair amounts of rRNA de-
rived tags. To investigate the effects of chemotherapy in vi-
vo, tags derived from rRNA molecules were counted in the
AIDS-KS and control libraries (Table 6). 18S and also 28S
rRNA tag counts have dropped significantly 24 hrs after
the start of chemotherapy (KS-24), compared with un-
treated AIDS-KS tissue and normal skin, in line with the in
vitro findings. Mitochondrial rRNA tag counts are, howev-
er, in the normal range. Interestingly, the two libraries de-
Table 1: Frequency distribution of tag counts in the four KS and control SAGE libraries
Librarya Tag count
 >75
Tag count
 = 25 – 75
Tag count
 = 5 – 24
Tag count
 = 2 – 4
Tag count
 = 1
Total tagsb Unique tagsc
KS-24 45 124 1055 4484 15102 47298 20810
KS-48 34 134 892 3926 16498 46671 21484
KSa 57 143 1317 3518 11326 49335 16361
KSb 67 151 1146 3444 12075 48814 16883
CD4 39 135 999 4539 17956 51886 23668
NS 41 128 866 2908 11373 39492 15318
a Libraries are: KS-24, AIDS-KS tissue 24 hrs after chemotherapy; KS-48, AIDS-KS tissue 48 hrs after chemotherapy; KSa and KSb, AIDS-KS tissue 
from two untreated patients, CD4, isolated CD4+ T-cells from a single donor; NS, normal skin from three breast reductions. b Tag numbers after 
elimination of linker-based tags and duplicate ditags. c Number of unique tags identified in each library.
Table 2: Transcripts differentially expressed between the four KS 
SAGE a
KS-24 KS-48 KSa
KS-48 306
KSa 367 234
KSb 374 250 131
a Transcripts differentially expressed at a significance level of p < 0.01.BMC Cancer 2002, 2 http://www.biomedcentral.com/1471-2407/2/21
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rived from untreated material at autopsy contain very low
mitochondrial rRNA tag counts.
Increase in tags containing poly(A) sequences in KS-24
The SAGE technique detects the 3' ends of mRNAs
through their poly(A) tails. As such, transcripts undergo-
ing severe degradation of the poly(A) stretch, e.g. during
apoptosis, will not be captured and thus not be detected.
Poly(A)-tails represent the only general motif that can be
analyzed using SAGE to check for eventual mRNA degra-
dation. To investigate whether tags containing part of the
poly(A) tail are differentially detected in library KS-24 ver-
sus the other libraries, all tags ending with poly(A)6–10
were counted in the AIDS-KS and control libraries. Manu-
al checking of these tags within their mRNAs, showed that
indeed >98% of them represent the start of the poly(A)
stretch, and do thus not represent internal tags. From Ta-
ble 7 it can be seen that tags ending with (A)6–10 are actu-
ally higher in KS-24, or lower in the other AIDS-KS
libraries. NxAy (where x = 4–0 and y = 6–10) tags increase
from 0.06–0.13 % in KSa/KSb/KS-48 to 2.04 % in KS-24,
a 15–34 fold increase. Tag A10 is increased around 50 in
Table 3: Pearson correlation coefficients obtained from variation analysis of the six SAGE libraries
KS-24 KS-48 KSa KSb NS CD4
KS-24 1.00
KS-48 0.55 1.00
KSa 0.38 0.58 1.00
KSb 0.37 0.67 0.83 1.00
NS 0.65 0.67 0.68 0.63 1.00
CD4 0.51 0.92 0.51 0.66 0.53 1.00
Table 4: Twenty-five most frequent tags from SAGE library KS-24
Tag Count Percentage Identification(s) Unigene cluster
CTAAGACTTC 588 1.24 Mt 16S rRNA -
CCTGTAATCC 308 0.65 Multiple (>20) -
CTCATAAGGA 281 0.59 Mt 16S rRNA -
ATAATTCTTT 276 0.58 RP S29 Hs 539
CCACTGCACT 267 0.56 Multiple (>20) -
AAAAAAAAAA 255 0.54 Multiple (>20) -
GTGAAACCCC 227 0.48 Multiple (>20) -
TACCATCAAT 222 0.47 Glyceraldehyde-3-phosphate-dehydrogenase Hs 169476
ATTCTCCAGT 193 0.41 RP L23 Hs 234518
TGCACGTTTT 177 0.37 RP L32 Hs 169793
TTCATACACC 173 0.36 Mt NADH-dehydrogenase subunit 4L -
CACCTAATTG 165 0.35 Mt ATP-synthase 6 and 8 -
TAGGTTGTCT 153 0.32 Tumor protein, translationally controlled 1 Hs 279860
CCTAGCTGGA 152 0.32 Peptidylprolyl isomerase A (Cyclophilin A) Hs 182937
GGATTTGGCC 149 0.32 RP large P2 Hs 119500
TGTACCTGTA 146 0.31 Tubulin, alpha, ubiquitous Hs 278242
GTGAAACCCT 140 0.30 Multiple (>20) -
TTGGTCCTCT 140 0.30 RP L41 Hs 324406
AACTAAAAAA 130 0.28 RP S27a Hs 3297
GAGGGAGTTT 124 0.26 RP L27a Hs 76064
CTGGGTTAAT 121 0.26 RP S19 Hs 298262
TTCAATAAAA 116 0.25 Multiple (3) -
AAAACATTCT 115 0.24 Mt 16S rRNA -
TTGGCCAGGC 107 0.23 Multiple (>20) -
TAATAAAGGT 106 0.23 RP S8 Hs 151604BMC Cancer 2002, 2 http://www.biomedcentral.com/1471-2407/2/21
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KS-24 compared with the other AIDS-KS libraries (Table
7). Interestingly, Table 8 showed that at least two poly(A)
binding protein mRNAs (PABP1 and -2), whose encoded
proteins are involved in stabilization of mRNA, are also
expressed at high levels in KS-24. This suggest that the ob-
served increase in poly(A) tags could be due to increased
protection of mRNA by PABP's. In normal skin, PABP1,
but not PABP2, is expressed at the same level as in KS-24.
Overall, these findings suggests that the mRNA pool
which generated library KS-24 contained on an average
longer poly(A)-tails than the other libraries.
Table 5: Transcription profile of untreated AIDS-KS compared with KS-24 and normal skin (NS) a
Tag Identification KS-24 (treated) KS (untreated) NS
GACCGCAGGA Collagen, type IV, 10 1 1 7 1
GTGCGCTGAG MHC, class I C 1 93 1
CGTGGGTGGG Heme oxygenase (decyling) 1 0 171 5
CTCTAAGAAG Complement component 1q subcomponent  peptide 0 40 1
GAGAGTGTCT Tissue inhibitor of metalloproteinase, collagenase inhibitor 
(TIMP)
13 1 1
GCGGTTGTGG Lysosomal-associated multispanning membrane protein 5 0 28 1
CGGGGTGGCC Cartilage oligomeric matrix protein 0 28 0
GCAAGAAAGT Hemoglobin  02 4 0
ACCGCCGTGG Cytochrome b-245,  polypeptide 0 22 1
CCGGGTGATG ATX1 (antioxidant protein1) 5 22 1
GCTGCGGTCC H2A histone family member 0 19 1
GTGTTAACCA Ribosomal protein L15 13 19 1
ACCATTCTGC Interferon induced transmembrane protein 2 (1-8D) 0 19 1
GGCTCCCACT Heat shock 90 kD protein1, beta 8 18 0
CGGGATTCCT Phospholipid transfer protein 0 18 1
GCTGGTGCCT Thy-1 cell surface antigen 0 17 1
TACAGTATGT Glutamate-ammonia ligase, glutamine synthase 11 17 1
GAGCAGCGCC S100 calcium binding protein A7 (Psoriasin) 0 101 8
ACTTTAGATG Collagen type VI 30 3 3 3
GTGGCCACGG S100 calcium binding protein A9 (Calgranulin) 1 96 8
GCCCCTCCGG 16,7 Kd protein 3 16 1
AGTAGCCGTG No reliable matches 13 16 1
ACAGGGTGAC Endothelial differentiation-related factor 1 3 15 1
TGGAGAAGAG Thioredoxin interacting protein 0 15 1
TGTCATCACA Lysyl oxidase-like 2 0 15 1
TCAGACGCAG Prothymosin  91 56 6
a All libraries were normalized to tag number per 50.000
Table 6: Tag counts derived from ribosomal RNAs in the six SAGE libraries a
rRNA KS-24 KS-48 KSa KSb NS CD4
Mt 12S (3 tags) 189 474 69 24 78 879
Mt 16S (4 tags) 1025 573 33 44 164 1043
Total mitochondrial 1378 (2.91 %) 1047 (2.24%) 102 (0.21%) 68 (0.14%) 242 (0.61%) 1922 (3.70%)
18S (8 tags) 50 931 401 883 134 1626
28S (8 tags) 33 354 134 164 68 461
Total nuclearb 83 (0.18%) 1285 (2.75%) 535 (1.08%) 1047 (2.15%) 202 (0.51%) 2087 (4.02%)
a Libraries have not been normalized b No NlaIII sites are present in the 5S and the 5.8S rRNA genesBMC Cancer 2002, 2 http://www.biomedcentral.com/1471-2407/2/21
Page 7 of 12
(page number not for citation purposes)
Discussion
SAGE is a widely used technique to analyze the transcrip-
tome of cells and tissues. Here, we have studied mRNA
populations expressed in AIDS-KS tissue of a single pa-
tient, 24 and 48 hrs after chemotherapy with a cocktail of
doxorubicin, bleomycin and vincristine (libraries KS-24
and KS-48, respectively), and compared them with SAGE
libraries generated from similar tissue of two untreated
patients (libraries KSa and KSb). Resistance to the chemo-
therapy was not observed, as the patient already improved
upon the first treatment, and all KS lesions finally resolved
after five courses. All three anti-cancer drugs are able to in-
duce cell cycle arrest and apoptosis in proliferating cells
through damage of the DNA. Inhibition of DNA replica-
tion and RNA transcription are other common effects. In
vitro investigations show that the drugs are capable of up/
down regulating specific genes [21,34,36–38].
The tag counts of the four libraries ranged from 46,671 –
49,335 tags. Libraries KS-24 and KS-48 had slightly higher
unique tag counts than KSa and KSb (~20,000 versus
~16,500). Tag frequencies were similar between the four
libraries, albeit that KS-24 and KS-48 contained more sin-
gle tags than the other two libraries (~15,500 versus
~11,500). So, from the general characteristics of the SAGE
libraries, chemotherapy does not seem to create signifi-
cant problems when constructing a SAGE library. Com-
paring relationships based on gene expression profiles,
libraries KS-48, KSa, and KSb were more closely related to
each other than to KS-24. However, correlation analysis
showed that library KS-48 was almost identical to a library
generated from CD4 T-cells, suggesting that the RNA ex-
tracted from the KS-48 tissue is derived from tumor infil-
trating T-cells, possibly because the AIDS-KS cells are still
suffering from cell cycle arrest at this time-point. In pacli-
taxel-treated breast cancer patients, the attraction of tu-
mor infiltrating lymphocytes (TILs) after treatment,
probably resulting from drug-induced apoptosis, was
found to be an indicator of favorable outcome [39]. In the
patient described in this paper, a good response to chem-
otherapy and a complete recovery from AIDS-KS was ob-
served, suggesting that the development of TILs after
chemotherapy is also a predictor of clinical response in
AIDS-KS. Most likely, these infiltrating lymphocytes are
CD8+ T-cells, allowing for the slight discrepancy between
the KS-48 and CD4 SAGE libraries (Pearson correlation
coefficient = 0.92).
Table 7: Frequency of tags ending with multiple A-nucleotides in the AIDS-KS and control SAGE libraries a
Tag KS-24
47298 tags
KS-48
46671 tags
KSa
49335 tags
KSb
48814 tags
NS
39492 tags
CD4
51886 tags
AAAAAAAAAA 255 4 6 5 45 15
NAAAAAAAAA 178 4 7 5 38 12
NNAAAAAAAA 184 5 23 23 136 39
NNNAAAAAAA 101 5 11 3 37 23
NNNNAAAAAA 245 10 18 20 32 56
Total % 2.04 0.06 0.13 0.13 0.73 0.28
a Libraries have not been normalized
Table 8: Poly(A) binding protein tags in the AIDS-KS and control SAGE libraries a
Identification Tag KS-24
 47298 tags
KS-48
 46671 tags
KSa
 49335 tags
KSb
 48814 tags
NS
 39492 tags
CD4
 51886 tags
Poly(A) binding protein, 
nuclear 1 (PABP2) Hs 117176
A A T A A A G T T G 1 1 00070
G T A T T C C C C T 2 8 35216
Poly(A) binding protein, 
cytoplasmic 1 (PABP1) Hs 172182
AAAAGAAACT 25 2041 8 3
a Libraries have not been normalizedBMC Cancer 2002, 2 http://www.biomedcentral.com/1471-2407/2/21
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The significant divergence of library KS-24 suggests a ma-
jor impact of chemotherapy on the cellular transcriptome,
in line with earlier experiments [1]. In summary, the main
results from SAGE analysis of anti-cancer drug-treated tis-
sue were: 1. Transcripts found to be highly and specifically
expressed in AIDS-KS were lacking or low, 2. Nuclear ri-
bosomal RNA levels have declined, and 3. mRNAs with
long(er) poly(A)-tails were abundant. Results 1 and 2 are
likely to be due to inhibition of transcription, and subse-
quent degradation of RNA. Lam et al.[40], analyzing the
transcriptional effect of several anti-cancer drugs on mi-
cro-arrays, found that transcriptionally inducible genes
often have short half-lives of less than 4 hrs. The major
classes of unstable transcripts include those encoding cy-
tokines, chemokines, and apoptosis- and cell cycle regula-
tors. Thus, 24 hrs after drug-treatment, resulting in
repression of de novo transcription, most unstable tran-
scripts likely have disappeared from the cells. Doxoru-
bicin treatment of cells in vitro results in a complete shut
down of transcription, possibly because doxorubicin in-
hibits the activity of RNA polymerase II [37]. Topoisomer-
ase II inhibition by doxorubicin could explain the severe
effects of this drug on RNA polymerase I and -III promot-
ers [35]. Most likely, the transcripts found to be highly ex-
pressed in AIDS-KS, which include collagens, keratins,
S100 calcium-binding proteins, MHC components, and
integrins, have relatively short half-lives, and are thus no
longer present in KS-24.
Another characteristic of KS-24 are the relatively longer
poly(A)-tails and the increase of nuclear PABP2 tags, sug-
gesting that a "better" protected and probably longer-lived
mRNA pool has been isolated. PABP's bind to poly(A)-
tails to protect mRNAs from ribonuclease attack and rapid
decay (for a review on the regulation of mRNA stability in
mammalian cells, see: [41]). Two classes of nuclear po-
ly(A) RNA with different half-lives, 2.5 hrs and 8–12 hrs,
respectively, have been described earlier in growing cell
cultures [42]. A stable population of nuclear poly(A)+
RNA can be found in interchromatin granule clusters
(IGCs), also known as speckles. IGCs contain compo-
nents of the pre-mRNA splicing machinery, and are in-
volved in mRNA processing (see: [43]). Inhibition of RNA
polymerase II transcription in vitro results in the fusion of
these IGCs [44]. At the same time, poly(A)+ RNA levels in
the nucleoplasm decreased significantly. Brawerman and
Diez [45] noted unusually long poly(A) segments in the
nucleus after a transcription block in rodent cells, proba-
bly because poly(A) addition continues in the absence of
de novo transcription. So, the cell nucleus apparently con-
tains a population of long-lived poly(A)+ RNA in IGCs,
which upon transcription inhibition reorganize into larg-
er IGCs. At the same time, additional extension of the po-
ly(A) tails takes place, and nucleoplasmic poly(A)+ RNA
is lost. Nuclear PABP2 protein has been detected in isolat-
ed IGCs [46]. Recently, mRNA from messenger ribonucle-
oprotein complexes, mRNPs, has been analyzed on cDNA
arrays [47]. Three types of mRNP complexes (HuB, eIF-4E,
and PABP) were found to contain mRNA profiles signifi-
cantly different from each other and from the total RNA
pool. An interesting feature of the mRNA subset isolated
from PABP-mRNP complexes was the high amount of RP
S29 mRNA in these complexes compared with the total
RNA profile, in line with the abundance of RP S29 tags
seen in KS-24. PABP-mRNP complexes further contained
higher levels of mRNAs for glyceraldehyde-3-phosphate
dehydrogenase and RP L32, for both of which tag num-
bers were also increased in KS-24 (ten-fold and two-fold,
respectively, result not shown). So, it is likely that the RNA
Figure 3
Effect of chemotherapy in cycling cells. Drug-induced
DNA damage, results in G2/M checkpoint-arrest and inhibi-
tion of RNA transcription. Twenty-four hours after drug
treatment only long-lived mRNA's can be isolated, most
likely residing in PABP-mRNP complexes.BMC Cancer 2002, 2 http://www.biomedcentral.com/1471-2407/2/21
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profile of KS-24 is mainly derived from mRNA contained
in PABP-mRNP complexes (see Fig. 3).
Another factor likely to distort the mRNA profile after
anti-cancer drug-treatment is the ability of chemothera-
peutic agents to inhibit cell cycle progression at a certain
point. Analyzing the pattern of gene expression during the
cell cycle, oscillation of many mRNAs, including genes
known to be involved in cell cycle control, was detected
[48]. Earlier reports indicated that the three drugs admin-
istered to the patient analyzed here all block cells in late
G2, just before start of mitosis. Genes expressed at high
levels during G2 in the mouse include cyclin B1, and
cdc20 (see also [48]), both of which are elevated in KS-24.
In line with this, doxorubicin was found to induce cyclin
B1 accumulation in cell cultures [49,50]. Cyclin B1 tags
are approximately 5-fold induced in KS-24, tags for cdc20
are absent from all libraries except KS-24, which contains
9 tags /50.000. Increased tags for cyclin B2 (4 tags/50.000
in KS-24, none in the other libraries) also point at inhibi-
tion at the G2/M boundary in KS-24. Cyclin D3 tags are el-
evated in KS-24, but cyclin D3 is not cell cycle regulated
and its concentration depends upon the growth rate of the
cell. During mitosis there is no significant transcription,
resulting in a reduction of poly(A)+ RNA and protein syn-
thesis. It is possible that a large number of mRNAs, in-
cluding those for the PABP's themselves, are before this
stage assembled into complexes, to have them ready for
translation at the next phase of the cell cycle. If this is true,
the observation of an increase in PABP-bound mRNAs in
KS-24 could be directly associated to cancer cells being
blocked at the G2/M transition. Poly(A) polymerase
(PAP) activity is cell cycle regulated, with enzyme activity
being low during mitosis [51].
Analysis of gene expression patterns in vivo after antican-
cer drug treatment in AIDS-KS suggest that the RNA pro-
file is dramatically influenced by the extraction of subsets
of mRNA present in mRNP complexes, as well as by a
block in transcription, resulting in differences in stability
of individual mRNAs becoming highly important. Cell cy-
cle effects are also likely to be important, as the expression
of many genes fluctuates with the phase of the cell cycle.
The findings reported here oppose the common idea that
the main effect of chemotherapy is found in the specific
up- or downregulation of gene expression, whereby the
genes found to be affected play an important role in the
reaction of the cell upon the anti-cancer drug. This could
be an effect at low concentrations, but is unlikely to be the
main effect of chemotherapeutic agents at effective plas-
ma levels.
Conclusions
Analysis of gene expression patterns in vivo after antican-
cer drug treatment in AIDS-KS suggest that the RNA pro-
file is dramatically influenced by the extraction of subsets
of mRNA present in mRNP complexes, as well as by a
block in transcription, resulting in differences in stability
of individual mRNAs becoming highly important. Cell cy-
cle effects are also likely to be important, as the expression
of many genes fluctuates with the phase of the cell cycle.
The findings reported here, although be it in a single pa-
tient, oppose the common idea that the main effect of
chemotherapy is found in the specific up- or downregula-
tion of gene expression, whereby the genes found to be af-
fected play an important role in the reaction of the cell
upon the anti-cancer drug. This could be a possible effect
at low concentrations, but is unlikely to be the main effect
of chemotherapeutic agents at effective plasma levels.
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Methods
Patient
A 31-year old man was demonstrated to be HIV-1 serop-
ositive in February 1997. The initial CD4 cell count was
25  106/ l. The patient presented within two months a
mucocutaneous Herpes simplex infection and an ex-
trapulmonary Cryptococcosis for which specific medica-
tion was given. The HIV-1 RNA load at presentation was
15,000 copies/ml and increased to 33,000 copies/ml in
three months. Then antiretroviral therapy was started with
zidovudine, lamivudine and indinavir. After 4 weeks of
treatment his plasma HIV-1 copy number had declined to
below the assay detection limit (1000 copies/ml). Six
months later the patient presented with gradual appear-
ance of an increasing number of violaceous skin lesions in
the perianal region and on the face that clinically resem-
bled KS. The diagnosis was confirmed by histological ex-
amination of one of the lesions. A serum sample taken
earlier was found to be positive for HHV8 antibody. In
view of the rapidly progressive and extensive nature of the
disease, systemic chemotherapy with bleomycin (15 mg),
vincristine (2 mg) and doxorubicin (10 mg/m2) was start-
ed. At this time KS had progressed to about 150 cutaneous
lesions. Antiretroviral therapy was continued unchanged.
The interval between the courses of chemotherapy was
three weeks, and five courses were given. Following the
first course of chemotherapy no new KS lesions appeared
during the first month and about two thirds of the existing
lesions had disappeared. Complete remission was gradu-
ally reached after one year. During chemotherapy several
biopsies were taken. The first biopsy was obtained 24
hours after the start of the chemotherapy (named KS-24)
and the second biopsy was taken after 48 hours (named
KS-48). Two biopsies were flash-frozen in liquid nitrogen
immediately after neurosurgical removal and stored at -
80C. Another biopsy taken from the same lesion was
used for histological analysis. Diagnosis of AIDS-KS wasBMC Cancer 2002, 2 http://www.biomedcentral.com/1471-2407/2/21
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confirmed histopathologically (Fig. 1a, 1b). About 30–
40% of the biopsies consisted of tumor specific spindle
cells.
SAGE libraries KSa and KSb were made from frozen mate-
rial taken at autopsy from two untreated AIDS-KS pa-
tients, both of which died in 1986 (Cornelissen et al.,
manuscript submitted). Additionally, a control SAGE li-
braries of 39,492 tags was generated from the pooled nor-
mal skin samples of three patients undergoing reduction
mammoplasty (library NS), and another control library of
51,886 tags was made from isolated CD45+CD4+ T-cells
from a healthy blood donor (library CD4). Control librar-
ies KSa, KSb and NS have been described elsewhere (Cor-
nelissen et al., manuscript submitted).
SAGE library construction
CD4+ T-cells were depleted from peripheral blood mono-
nuclear cells from a single healthy donor by the use of
CD4-coated immunomagnetic beads (miniMACS, CLB,
The Netherlands). Total RNA was isolated from the two
AIDS-KS biopsies and from 1.9  107 CD4+ T-cells using
Trizol reagent (Life Technologies, San Diego CA, USA).
Poly(A)+ RNA was further isolated using the Micro-Fast-
Track 2.0 messenger RNA (mRNA) purification kit (Invit-
rogen, Carlsbad CA, USA) according to the manufacturer's
protocol. SAGE was performed as described previously
[23,52]. In short: synthesis of cDNA was performed using
Superscript II RNAse H-reverse transcriptase (Life Tech-
nologies, San Diego CA, USA) and a primer biotin-5'-T18-
3'. The cDNA was then cleaved with NlaIII, and the 3' re-
striction fragments were isolated with magnetic streptavi-
din-coated beads (Dynabeads M280 from Dynal, Oslo,
Norway). Oligonucleotides containing BsmF1 recognition
sites were ligated to the fragments bound to the beads,
and tags were released from the beads by BsmF1 digestion.
Tags were ligated to create ditags, and amplified by 26–28
PCR cycles. NlaIII digested, amplified ditags were subse-
quently concatenated and cloned using the Zero Back-
ground cloning kit from Invitrogen (Carlsbad CA, USA).
Colonies were screened by PCR using M13 reverse or (-)
21M13 primers, and inserts were sequenced with the
Bigdye Terminator Cycle Sequencing kit (ABI, Foster City
CA, USA) and analyzed with an ABI 377 automated se-
quencer (ABI, Foster City CA, USA), following the manu-
facturer's protocols.
Analysis of SAGE libraries
Primary analysis of the SAGE libraries was performed with
the program USAGE version2 [53]. This program is able to
do initial analyses on raw sequence data, e.g. ditag and tag
extraction, tag counting, and tag identification. Tags are
identified with the tag-to-gene mapping of the SAGEmap
database and a tag-to-gene mapping database established
as part of the Human Transcriptome Map [54]. In this lat-
ter identification, the SAGEmap database from NCBI  [ht-
tp://www.ncbi.nlm.nih.gov/SAGE] has been corrected for
common errors, mostly due to sequencing errors in pub-
licly available sequences.
Secondly, the USAGE program was used to compare SAGE
libraries, and to do statistical analyses on tag count differ-
ences. For this, USAGE implements the method proposed
by Kal et al[55].
The programs Cluster and TreeView ([56],  [http://
www.microarrays.org/software.html] were used to per-
form hierarchical clustering on the SAGE data, and to vis-
ualize the resulting tree, respectively.
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